How (Not) to Do an Antibody Survey for SARS-CoV-2
By Catherine Offord
Preprints from the first round of seroprevalence studies indicate that many more people have been infected with the virus than previously reported. Some of these studies also have serious design flaws.
NIH Cancels Funding for Bat Coronavirus Research Project
By Shawna Williams
The abrupt termination comes after the research drew President Trump’s attention for its ties to the Wuhan Institute of Virology.
Enter Our Annual Top 10 Innovations Contest
By The Scientist Staff
Submit your new product now to have a chance at being selected for a coveted spot in The Scientist’s 2020 competition.
ICYMI: What Do Antibody Tests For SARS-CoV-2 Tell Us About Immunity?
By Katarina Zimmer
Studies from serum samples could transform our understanding of the spread of COVID-19, but what antibodies alone say about immunity is not yet clear.
Watch the Spread of COVID-19
Our maps and charts, updated regularly, offer a striking view of the global move of the novel coronavirus.
Experimental Strategies for Successful CRISPRa Implementation
By The Scientist Creative Services Team
High-Resolution Analysis of the Tumor Microenvironment Using Single Cell Gene Expression
Never miss an email from The Scientist. Click here to add The Scientist to your safe-sender list.
The Scientist c/o LabX Media Group, 478 Bay Street, Suite A213 Midland Ontario Canada, L4R 1K9 Toll-Free: (888) 781-0328 | Phone: (705)528-6888Email: privacy@labxmediagroup.com
You received this email because you are subscribed to The Scientist Daily from The Scientist Click to Unsubscribe | View Privacy Policy
.jpg?upscale=true&width=1456&upscale=true&name=DeNovix-Pink-CellDrop-728x90%20(1).jpg)
.jpg?upscale=true&width=600&upscale=true&name=DeNovix-Pink-CellDrop-300x250%20(1).jpg)
